Ujin Pharma Limited - business services in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U46691MH2024PLC425527 Incorporated 21 May 2024 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹6.9 Cr
Registered with MCA
Paid-up capital
₹5.88 Cr
Issued & subscribed
Open charges
₹378.8 Cr
Secured borrowings
Company age
2 yrs
Est. 2024
Employees · EPFO
-
Latest available

About Ujin Pharma Limited

Data last updated: 21 December 2025

Ujin Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. Incorporated on 21 May 2024.

Registered with ROC Mumbai under CIN U46691MH2024PTC425527.

Capital: an authorised share capital of ₹6.9 Cr and a paid-up capital of ₹5.88 Cr. It is led by directors including Jinesh Rasiklal Sheth and Neha Umang Mehta.

Office: 6Th Neelkanth Corporate Park, Mumbai, Maharashtra.

As per MCA filings, the company has open charges of ₹378.8 Cr on record.

For more details, the company can be reached via its website ujinpharma.com.

Company Details of Ujin Pharma Limited
CIN U46691MH2024PLC425527
Registration Number 425527
Incorporation Date 21 May 2024
ROC Mumbai
Listing Status Unlisted
Company Status Active
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    610/6Th Neelkanth Corporate Park, Kirol Road Vidyavihar West, Mumbai, Maharashtra, India – 400086
Company report
Ujin Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ujin Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Ujin Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Ujin Pharma Limited

Ujin Pharma Limited has one previous CIN (Corporate Identification Number): U46691MH2024PTC425527. The current CIN is U46691MH2024PLC425527, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U46691MH2024PLC425527 Current
U46691MH2024PTC425527 Previous

Board of Directors of Ujin Pharma Limited

Ujin Pharma Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Jinesh Rasiklal Sheth Managing Director 21 May 2024 2 Years 1 Months Current
Neha Umang Mehta Director 28 Apr 2025 1 Years 2 Months Current
Umang Ketan Mehta Director 21 May 2024 2 Years 1 Months Current

Financials of Ujin Pharma Limited

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Ujin Pharma Limited

Open charges
₹378.8 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹307.80 Cr
Yes Bank Limited₹40.00 Cr
Axis Bank Limited₹31.00 Cr
Latest charge details
DateLenderAmountStatus
03 Oct 2025 Others ₹50 Lakh Open
13 Aug 2025 Others ₹20 Cr Open
25 Apr 2025 Others ₹25 Cr Open
22 Jan 2025 Yes Bank Limited ₹40 Cr Open
16 Jan 2025 Others ₹35 Cr Open

Total charge records: 10 View all charges

Employees and EPFO Compliance at Ujin Pharma Limited

View historical data on people associated with Ujin Pharma Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Ujin Pharma Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Ujin Pharma Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Ujin Pharma Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Ujin Pharma Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Ujin Pharma Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Ujin Pharma Limited

MSME Payment Delays by Ujin Pharma Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Ujin Pharma Limited

Subsidiaries & Group Companies of Ujin Pharma Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ujin Pharma Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Ujin Pharma Limited

MCA Filings & Documents of Ujin Pharma Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Ujin Pharma Limited

Charges
15 Nov 2025
A charge with Others of Rs. 75.00 Cr registered on 28 Nov 2024 with Charge ID 101016278 was modified on 15 Nov 2025.
Charges
31 Oct 2025
A charge with Others of Rs. 25.00 Cr registered on 25 Apr 2025 with Charge ID 101088645 was modified on 31 Oct 2025.
Charges
03 Oct 2025
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 101180009 was registered on 03 Oct 2025.
Charges
13 Aug 2025
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101149425 was registered on 13 Aug 2025.
Directors
28 Apr 2025
Neha Umang Mehta was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 2 months.
Charges
25 Apr 2025
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101088645 was registered on 25 Apr 2025.

Frequently Asked Questions about Ujin Pharma Limited

Ujin Pharma Limited is an active public limited company based in Mumbai, Maharashtra, India. It was incorporated on 21 May 2024 (2+ years old) and is registered under CIN U46691MH2024PLC425527.

The current directors of Ujin Pharma Limited are:

Ujin Pharma Limited can be reached at the registered office: 6106Th Neelkanth Corporate Park, Kirol Road Vidyavihar West, Mumbai, Maharashtra, India – 400086, or through the website ujinpharma.com.

The authorised capital is ₹6.9 Cr, and the paid-up capital is ₹5.88 Cr.

The company has its registered office at 6106Th Neelkanth Corporate Park, Kirol Road Vidyavihar West, Mumbai, Maharashtra, India – 400086.

Ujin Pharma Limited was incorporated on 21 May 2024, making it 2+ years old. Registered with ROC Mumbai.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available